We Help Companies Find New Sales Opportunities
Chemicals & Pharmaceuticals - 2013
AstraZeneca is to buy US-based Bristol-Myers Squibb out of their diabetes treatments joint venture for up to £2.5bn, with the transfer of about 4,100 staff.
Ceramic Fuel Cells is to sell its powder plant assets in Bromborough to ICL-PP Europe for £1.2m.
Alliance Pharma has acquired the UK rights to the Lypsyl personal care brand from Novartis for £1.8m.
AM Technology, the chemical manufacturing technology firm, has acquired an 11,000 sq ft unit at Berkeley Court in Runcorn.
Lallemand UK has bought the Oban-based marine biotechnology business of Aquapharm Bio-Discovery out of administration.
GlaxoSmithKline is to invest £200m in the expansion of pharmaceutical plants in Hertfordshire and West Sussex, with the creation of an unspecified number of jobs.
Plymouth University is planning to develop a research and education facility at the AstraZeneca environmental laboratory in Brixham next year.
Venn Life Sciences has acquired Medevol, the Belfast-based clinical trials firm, for up to £0.7m.
Johnson & Johnson is opening offices in Cambridge, Cardiff, Edinburgh, Manchester and Oxford, in order to benefit from university medical research.
University of Birmingham is to open a new £6.8m Biomedical Innovation Hub next summer, in order to provide laboratory and office space for local biomedical firms.
AZ Electronic Materials, the speciality chemicals supplier with a global workforce of 1,100, is to be acquired by Merck of Germany for £1.6bn.
Metalysis is seeking financial support to build a titanium powders plant in Yorkshire, in order to manufacture ink for 3D printing.
GlaxoSmithKline is to invest £25m in the expansion of its pharmaceuticals plant in Montrose, with the creation of 25 jobs.
Bodybuilding Warehouse is to set up a 21,000 sq ft sports supplements warehouse at the Guinness Road Trading Estate in Manchester.
AstraZeneca is to relocate up to 400 research scientists to three temporary sites in Cambridge next year, in preparation for the 2016 opening of its new £330m headquarters.
The University of Sussex is planning a £500m expansion programme, including a new facility for genetics, drug discovery and neuroscience research.
Tissue Regenix has submitted plans to build a new 12,000 sq ft headquarters for its medical technology business at Northminster Business Park in York by the end of next year.
Fine Industries, the Teesside-based chemicals manufacturer with 270 staff, has undergone a £25m management buy-out backed by NorthEdge Capital.
AstraZeneca is to invest £120m in the development of a new Zoladex production facility at its site in Macclesfield by 2017, securing the future of 300 jobs.
Takeda is to expand its pharmaceutical research facilities at the Cambridge Science Park with a new 42,000 sq ft building in 2015.
GlaxoSmithKline is to recruit 140 apprentices over the next two years, including 16 at its pharmaceuticals plant in Barnard Castle.
Sense is to build a £12m charity headquarters at the Life Sciences Economic Zone in Birmingham by 2016, with the relocation of 100 jobs and the creation of 100 new jobs.
Ineos is reopening its petrochemical plant at Grangemouth, as part of an agreement with unions that will involve a £300m investment in a new gas terminal.
Genea Biomedx is to set up a fertility research laboratory at Discovery Park in Sandwich, with the creation of 30 jobs.
DE Group, the Doncaster-based pharmaceutical wholesaler with 300 staff, has undergone a management buy-out backed by RBS Invoice Finance.
Corporate Solutions International is planning to expand the workforce at its Sedgefield-based drug and alcohol testing business from 18 to 80 by 2016.
AstraZeneca is to acquire Spirogen, the London-based drug development firm with 25 staff, for an initial £125m, in order to expand its MedImmune biologics division.
AstraZeneca has announced that its MedImmune biologics research division has acquired Spirogen, the biotechnology firm, for an initial £125m.
Glasgow University has secured a £10m government grant to develop a new clinical research facility for chronic diseases.
Cyprotex is setting up a new drug testing facility at BioHub in Alderley Park, Cheshire.
Hospira is relocating its pharmaceutical delivery business from Leamington Spa to a 26,000 sq ft office at the Horizon facility in Maidenhead.
Ineos is considering plans to invest a further £300m in the development of a new gas terminal at Grangemouth, on the condition that unions agree to some job cuts.
Clinigen Group is looking to create up to 90 jobs at its Burton-based pharmaceuticals business over the next few years.
S&D Sealants has acquired SEAM Sealants of Stourbridge for undisclosed terms, in order to expand its nationwide office network.
Phytopharm is to acquire IXICO, the London-based medical technology and diagnostics firm, in a £5.6m reverse takeover.
Centre for Process Innovation is planning to build a new £25m National Biologics Manufacturing Centre in Darlington, including laboratories and conference facilities.
Acdoco is to relocate its Blackburn-based cosmetics and cleaning products business to a 34,000 sq ft warehouse at Northbank Industrial Estate in Irlam.
Molecular Profiles, the Nottingham-based pharmaceuticals and clinical trials firm with 60 staff, has been acquired by US-based Columbia Laboratories for £16m.
Kent County Council has announced that an undisclosed Indian company is considering plans to set up a pharmaceutical manufacturing facility at Discovery Park in Sandwich, with the creation of more than 200 jobs.
Oxford BioMedica has secured funding of £7.1m to expand its Oxford-based biopharmaceutical manufacturing facilities over the next two years.
GroWell Hydroponics has bought Aquaculture Hydroponics of Sheffield out of administration, saving the five remaining jobs.
UDG is planning to set up a £20m 220,000 sq ft pharmaceutical and healthcare distribution centre at the Castlewood site in Derbyshire, with the creation of an initial 50 jobs.
AstraZeneca has won permission to build a 70,000 sq ft finished formulation facility at its pharmaceutical plant in Macclesfield, with the creation of 36 jobs.
Premaitha Health is planning to double the 12-strong workforce at its Manchester-based biotechnology business, having relocated from Cambridge.
Nitto Denko UK has won permission to expand its rubber and plastics manufacturing plant in Mansfield, with the creation of 30 jobs.
Forensic Science Northern Ireland has won approval to build a new £12m DNA processing laboratory at its Seapark site in Carrickfergus.
Thornton & Ross, the Huddersfield-based pharmaceuticals manufacturer with 440 staff, has been acquired by STADA Arzneimittel of Germany for £221m.
Saint-Gobain is to set up a 64,000 sq ft distribution centre for its International Decorative Surfaces business at Parkhouse Industrial Estate near Newcastle-under-Lyme by the end of the year.
Ineos ChlorVinyls has sold its Runcorn-based packed chlorine business to 2M Group for undisclosed terms.
LKQ Euro has acquired Iris Coatings and five automotive paint distributors with 26 depots for undisclosed terms, in order to expand its Euro Car Parts business.
PolyTherics is to merge with Cambridge-based Antitope to create a combined biopharmaceuticals group backed by Imperial Innovations.
ReNeuron is to relocate its Guildford-based stem cell research business and an initial 25 jobs to an undisclosed site in South Wales over the next two years.
Vindon Healthcare, the Rochdale-based manufacturer of environmental control products for the pharmaceutical industry, is in talks to be acquired by BioScience for £12m.
Imperial College London is linking up with 17 universities and 13 companies to form the £24m SynbiCITE Centre, in order to develop new technologies in synthetic biology.
Syntaxin, the Abingdon-based life sciences company specialising in compounds based on botulinum toxins, has been acquired by Ipsen of France for an initial £24m.
Victrex has won permission from Wyre Council to expand its PEEK chemicals plant in Thornton by 2015, with the creation of up to 20 jobs.
Liverpool School of Tropical Medicine is considering plans to expand its research buildings in Pembroke Place by up to 50,000 sq ft.
AbbVie, the biopharmaceutical company, is setting up a 13,000 sq ft office at the Quantum development in Maidenhead.
Evotec is to transfer the work of 120 staff in its chemistry operations from India to Abingdon, at a cost of up to £3.4m.
Intertek Group has acquired Melbourn Scientific, the Cambridge-based pharmaceutical testing firm with 80 staff.
Immunocore is to expand the 55-strong workforce at its Didcot-based biotechnology business with 25 new jobs this year.
AAH Pharmaceuticals is looking to recruit 50 additional warehouse staff and drivers at its warehouse in Talke, Staffordshire.
The University of Dundee has secured funding of £24m from the Medical Research Council, which will create 20 research jobs in its Protein Phosphorylation & Ubiquitylation Unit.
James Briggs, the Oldham-based chemicals manufacturer with about 200 staff, has undergone a management buy-out backed by Endless.
Orla Protein Technologies has secured funding to expand the workforce at its Newcastle-based life sciences business to 20 by the end of next year.
City Health Care Partnership of Hull has acquired Brocklehurst Chemists, the chain of three pharmacies, for undisclosed terms.
AstraZeneca has confirmed plans to develop a new £330m global headquarters for 2,000 staff at the Cambridge Biomedical Campus by 2016.
Eisai Manufacturing is to invest £8m in the expansion of its pharmaceutical manufacturing plant in Hatfield by summer 2014.
Norbrook Laboratories is to create 400 new jobs at its Newry-based veterinary pharmaceuticals business over the next two years.
Cleveland Biotech, the Stockton-based biotechnology firm with 16 staff, has undergone a £4.4m management buy-out backed by NVM Private Equity.
Everbuild Building Products, the Leeds-based manufacturer of sealants and adhesives with 270 staff, has been acquired by Sika of Switzerland.
Almac Pharma Services is to invest £14m in the expansion of its Armagh-based pharmaceutical manufacturing business, with the creation of 229 jobs.
RelayMed is looking to create at least 20 new jobs at its Edinburgh-based health diagnostics software business over the next two years.
Oxbow has won permission to build a sulphur processing plant at the Western Docks in Southampton, with the creation of 12 jobs.
Magstim has acquired Seren Medical, the Cardigan-based medical device manufacturer, takes its total workforce to 87.
Instem has acquired Logos Holdings, the London-based developer of clinical trials software, for up to £5m.
Redx Pharma is to set up a research and development centre at Alderley Park in Cheshire, with the creation of 120 jobs.
PRA of the US is planning to double the 100-strong workforce at its clinical research operation in Swansea, having acquired a larger office at the SA1 waterfront development.
Cerus Endovascular is to relocate from Oxford to the Liverpool Science Park, having secured an investment from the North West Fund for Biomedical to develop an implantable medical device.
Source BioScience has acquired Inverclyde Biologicals, the Motherwell-based manufacturer of diagnostic kits, for £1.6m.
Eastman is planning to invest tens of millions of pounds in a new plant to manufacture heat transfer fluids at the Solutia site in Newport by 2014, with the creation of 17 jobs.
Beiersdorf is to expand its skin care products warehouse at Holford Industrial Park in Birmingham by 80,000 sq ft, with the creation of 50 jobs.
The Scottish Funding Council is to help fund a £30m investment in three new life science innovation centres in Glasgow and Edinburgh, in order to provide genetic testing services and create up to 2,000 jobs.
Dechra Pharmaceuticals is setting up a new 3,000 sq ft headquarters on the Cheshire Business Park in Northwich.
Cleveland Potash is planning to invest up to £300m in the expansion of its potash mining and transport operations in Boulby and Teesport, with the creation of 220 jobs by 2015.
Life Technologies, the biotechnology firm with more than 500 staff in Renfrewshire, has been acquired by US-based Thermo Fisher Scientific for about £8.9bn.
Brunel Healthcare is seeking permission to expand its nutritional supplements factory in Swadlincote, with the creation of 60 jobs.
Daktari Diagnostics of the US has confirmed plans to set up a £12m medical devices factory in Inverness by next year, with the creation of 126 jobs.
The Welsh Government has announced plans to set up a new Life Sciences Hub in Cardiff Bay later this year, in order to encourage co-operation between academic, business and funding organisations.
Angel Biotechnology has sold its medical collagen operations out of administration to a new Glasgow-based company called Collbio.
Johnson & Johnson is to set up a life sciences innovation centre in London, in order to invest in the UK medical research industry.
GlaxoSmithKline is considering plans to relocate about 250 research and development jobs from Harlow to sites in Ware and Stevenage next year.
York Potash is to recruit 20 engineering apprentices in preparation for its proposed new mine near Whitby.
EKF Diagnostics has acquired 360 Genomics, the diagnostics technology firm, from Oxitec for an initial £1.6m.
Encap Drug Delivery, the Livingston-based pharmaceuticals manufacturer with 60 staff, has been acquired by US-based Capsugel for undisclosed terms.
Daktari Diagnostics of the US is considering plans to set up a new headquarters for its life sciences business in Scotland, which could create 126 jobs.
University of Dundee is to set up a £6.5m infectious diseases research centre, with the creation of 11 jobs.
Alstoe Animal Health, the York-based veterinary pharmaceuticals firm with 20 staff, has been acquired by Sogeval of France for undisclosed terms.
Rosemont, the Leeds-based pharmaceuticals manufacturer with 209 staff, has been sold by CBPE Capital to Perrigo Company of the US for £180m.
University of Dundee has secured funding from the European Innovative Medicines Initiative for a £100m drug discovery project at BioCity Scotland in Newhouse, with the creation of 40 jobs.
Sibelco UK has acquired Viaton Industries, the Derbyshire-based supplier of barite minerals for chemical use with 40 staff, for undisclosed terms.
Almac is to invest £6.5m in the expansion of its pharmaceutical laboratories in Craigavon over the next three years, with the creation of up to 60 jobs.
Cangenix, the Canterbury-based drug discovery firm, has been acquired by Galapagos of Belgium for an initial £1m.
Jeyes is to expand the 250-strong workforce at its Thetford-based cleaning products factory with 30 new jobs.
Redx Oncology is looking to recruit more than 60 scientists and technicians at its Liverpool-based research business.
The Roslin Institute has secured a £10m government grant to set up a livestock improvement centre in Midlothian.
Quotient Bioresearch has sold its bioanalytical sciences division to LGC for undisclosed terms.